show episodes
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Welcome to Concrete Conversations - the Indian Real Estate Podcast, where we converse with some of the brightest minds in Indian Real Estate to demystify the industry. Each episode features a different guest and will touch upon a different topic, ensuring that there’s something in it for everyone! You can catch us streaming on Spotify, Apple Podcasts, YouTube and a bunch of other platforms. So Stay Tuned for more Concrete Conversations!
  continue reading
 
Welcome to the DCTV Podcast – A place for spiritual Growth in a Transformational Church 🎙 Podcast Name: Destiny Church Tees Valley 🌐 Links: destinytees.uk | online.destinytees.uk | YouTube Transforming Lives through Faith, Hope, and Love About Destiny Church Tees Valley: Destiny Church is more than a place of worship; it's a community committed to bringing people to Jesus and fostering membership in His family. Our mission is to guide individuals to spiritual maturity in Christ, empowering t ...
  continue reading
 
Loading …
show series
 
Join us this morning @DestinyOnlineChurch for our 11am morning service. Today we celebrate Fathers day with a guest, Solomon Wada, from Four square Gospel Church. Listen to last weeks sermon: https://youtube.com/live/t1Jx6wrjVR4 Festival Teesside: https://www.festivalteesside.com Join a connect group: https://www.destinytees.uk/connect Connect with…
  continue reading
 
Today's episode explores the novel concept of Managed Farmland! Since Covid, we have seen a rise in plotted development launches across the outskirts of metros along with tier 2 & 3 cities, as people crave open space, clean environments and a connection to nature. As urban Indians start to put more thought into their health, wellness, and living a …
  continue reading
 
We love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the back of an MIT Ph.D. in biological engineering, having co-f…
  continue reading
 
We love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership …
  continue reading
 
We love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, …
  continue reading
 
Join us this morning @DestinyOnlineChurch for our 11am morning service, with the Word brought to us by Senior Pastor, Jonathan Harris. Today's message title is Go Fish Listen to last weeks sermon: https://youtube.com/live/t1Jx6wrjVR4 Festival Teesside: https://www.festivalteesside.com Join a connect group: https://www.destinytees.uk/connect Connect…
  continue reading
 
We love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contract developer, CTMC began with a more fundamental mission…
  continue reading
 
All over the world, we are seeing Climate change impact people's lives. The scope and complexity of the problem is massive, and solutions are often hard to implement. However, we know that Renewable energy, circular economies and sustainable practices all play a role, and that corporations, governments and the public are all stakeholders here. To t…
  continue reading
 
We love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current …
  continue reading
 
Join us today with worship and a message from Jonathan Harris. Today's message title is Lost & Found. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING Suppo…
  continue reading
 
We love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a …
  continue reading
 
Join Tracy today as she teaches on our co-mission with Jesus. Today's message title is Our Co-mission With Jesus Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFF…
  continue reading
 
Welcome back for an episode with a recurring guest! Over the past few years, the air quality in urban India has gone from a seasonal problem in certain cities to a growing concern among the entire urban population in India. This can be seen in the AQI or Air Quality Index in most Indian cities, with more days of the year in the "severe" and harmful…
  continue reading
 
We love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to …
  continue reading
 
Have a listen to Nadine as she continues the teaching on our identity. Today's message title is Who Is He? Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING …
  continue reading
 
We love to hear from our listeners. Send us a message. Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital eve…
  continue reading
 
Join Nadine today as she continues to teach on our identity. Today's message title is Who Are We. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING Support t…
  continue reading
 
We love to hear from our listeners. Send us a message. This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical…
  continue reading
 
Join Nadine today as she teaches on our identity. Her message is titled Who Am I.. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING Support the stream: http…
  continue reading
 
We love to hear from our listeners. Send us a message. Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with th…
  continue reading
 
We love to hear from our listeners. Send us a message. We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode, Karen's thoughtful perspective on the som…
  continue reading
 
Join us today as we celebrate Easter Sunday with Guest speaker John Andrews. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING Support the stream: https://st…
  continue reading
 
Join us today at 11am. Join us today as we finish our 40 Days of Purpose series. Today we are sharing what we have learnt and the testimonies that have unfolded during this series. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/Dest…
  continue reading
 
We love to hear from our listeners. Send us a message. Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artifical intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate Biomedicines, which bills itself at the "intersecti…
  continue reading
 
We love to hear from our listeners. Send us a message. Gavin Samuels, M.D. found his work as an intensive care physician boring. After earning his M.D., he did that for a few years before moving into intensive care management roles. It wasn't until he left the hospital and entered biopharma that he found his footing, cutting his teeth in business d…
  continue reading
 
Join us today at 11am. Join us today as we continue our 40 Days of Purpose series. Todays message title is 'Called To Be Sent' by Pastor Jonathan Harris. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT IN…
  continue reading
 
We love to hear from our listeners. Send us a message. Rob Williamson's mind and hands have shaped more than 20 biotech startups, leading some to IPO and landing others firmly in Big Bio through acquisition by companies like Merck. Hanging around as many successful exits as Williamson has seen, one might become expert via osmosis. But Williamson is…
  continue reading
 
Join us today as we continue our 40 Days of Purpose series. Todays message is 'Called to Bless' by Nkereuwem Ekanem. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING…
  continue reading
 
We love to hear from our listeners. Send us a message. In biotech, when "one of these things doesn't look like the other one," it can be a blessing or a curse. On one hand, scientific novelty is praised and rewarded. On the other, unfamiliarity breeds skepticism from the investment community. Brian Finrow, J.D. embraces that reality and the challen…
  continue reading
 
Join us today at 11am. Join us today as we continue our 40 Days of Purpose series. Todays message is 'Called to Become' by Deveshin Reddy. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.l…
  continue reading
 
Amongst emerging trends within the last 5 years, Fractional Ownership has become a popular concept to democratize Real Estate ownership for investors in India. According to a recent report from Knight Frank, the market for fractional ownership in India is projected to grow from $5.4 billion in 2020 to $8.9 billion in 2025. As this space grows, SEBI…
  continue reading
 
We love to hear from our listeners. Send us a message. Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the space to put on a precision medicine clinic, so to speak. What’s more, Radiopharmaceuticals create a unique business opportunity given the closely-related and necess…
  continue reading
 
Join us today at 11am. Join us today as we continue our 40 Days of Purpose series. Todays message is 'Called to Belong' by Tracy Reddy. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/D…
  continue reading
 
We love to hear from our listeners. Send us a message. While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge Senda Biosciences and Laronde, two of its programmable medicine platform companies. What you likely haven’t heard is the inside story on how the merger w…
  continue reading
 
We love to hear from our listeners. Send us a message. The concept of programmable biology is fueling a new breed of biotech, one that requires the marriage of computational and traditional science (and both computational and traditional scientists) on the entire journey from discovery to commercial. Bit.bio is exemplary of this new breed. Its CEO,…
  continue reading
 
We love to hear from our listeners. Send us a message. Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continues to save lives untold. It also demonstrated the collective power of public/private partnership in biopharma. Having acknowledged that, no first iterat…
  continue reading
 
Join us today at 11am. Todays message is Don't Waste Your Life by Pastor Jonathan. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING Support the stream: http…
  continue reading
 
We love to hear from our listeners. Send us a message. The Business of Biotech took a trip to San Francisco for the JP Morgan Healthcare Conference, that most target-richest of environments for those of us who like talking shop with biotech builders. The results of that trip will feed the next several weeks of Business of Biotech podcast programmin…
  continue reading
 
We love to hear from our listeners. Send us a message. Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies. The company’s a bit larger than those we typically cover on the Business of …
  continue reading
 
We love to hear from our listeners. Send us a message. We spend a lot of time talking with our guests about building biotech companies. That’s true of this episode too, but today we’re taking a step further with John Leonard, M.D., longtime CEO at Intellia Therapeutics. In addition to how he’s built late-clinical stage Intellia, Dr. Leonard shares …
  continue reading
 
Join us live at 11am today. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING COPYRIGHT INFO: Creative Commons Attribution license (reuse allowed) means you …
  continue reading
 
We love to hear from our listeners. Send us a message. Relatively new CEO Joseph Ferra has orchestrated some pretty significant change at Elevation Oncology in the two(ish) years since the Business of Biotech last hosted the company. In that short time, Ferra advance from CFO to CEO, a move that aligned very closely with the company's difficult dec…
  continue reading
 
Join us live at 11am. Links: https://bit.ly/myonlinechurch - ONLINE SERVICE http://bit.ly/destinyonlinewebsite - OUR WEBSITE http://bit.ly/destinychurchonline - OUR CHANNEL http://bit.ly/DestinyteesConnect - CONNECT INFO http://bit.ly/DestinyGive - GIVING/OFFERING COPYRIGHT INFO: Creative Commons Attribution license (reuse allowed) means you can us…
  continue reading
 
We love to hear from our listeners. Send us a message. A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On today's episode of the Business of Biotech, Lees sits down …
  continue reading
 
We love to hear from our listeners. Send us a message. Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, a former gastroenterologist-turned managing director and co-founder at Adelaide, Australia-based BiomeBank. We covered some ground on this one, most…
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we welcome two extraordinary guests - Dr. Neela Patel, a molecular biologist-turned-Chief Business Officer, and Dr. John Mulligan, an academic-turned-founder of newly-formed Bonum Therapeutics. Together, Neela and John will pull back the curtai…
  continue reading
 
We love to hear from our listeners. Send us a message. During his leadership of the President's Emergency Plan for AIDS Relief during the George W. Bush administraion, Dr. Mark Dybul, M.D. shepherded programs credited with saving more than 25 million lives. For many years after that public service drew to a close, he continued the mission as execut…
  continue reading
 
Loading …

Quick Reference Guide